We are seeking a $5 million SAFE note investment to commercialize our patented micelle drug delivery platform and launch our Minimum Viable Product (MVP).

Our innovative platform is designed to revolutionize drug delivery, and we are ready to accelerate our market entry. This funding will enable us to bring our MVP to market and scale operations.

Key Highlights:
* Commercialization of a patented micelle drug delivery platform.
* Launch of an MVP product.
* Seeking a $5,000,000 SAFE note.

We are prepared to move forward swiftly. We invite interested investors to connect with us to discuss this exciting opportunity.